Abstract

Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.

Details

Title
Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study
Author
Gómez-Acebo, Inés 1   VIAFID ORCID Logo  ; Dierssen-Sotos, Trinidad 1 ; Fernandez-Navarro, Pablo 2 ; Palazuelos, Camilo 3 ; Moreno, Víctor 4 ; Aragonés, Nuria 5 ; Castaño-Vinyals, Gemma 6 ; Jiménez-Monleón, Jose J 7 ; Ruiz-Cerdá, Jose Luis 8 ; Pérez-Gómez, Beatriz 5   VIAFID ORCID Logo  ; Ruiz-Dominguez, José Manuel 9 ; Jessica Alonso Molero 3 ; Pollán, Marina 2 ; Kogevinas, Manolis 6 ; Llorca, Javier 1 

 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; University of Cantabria – IDIVAL, Santander, Spain 
 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain 
 University of Cantabria – IDIVAL, Santander, Spain 
 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, and University of Barcelona, Barcelona, Spain 
 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Cancer Epidemiology Research Group. Oncology and Hematology Area. IIS Puerta de Hierro (IDIPHIM), Madrid, Spain 
 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain 
 CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Hospitales, Granada, Spain 
 Urology Department, La Fe University Hospital, Avinguda de Fernando Abril Martorell 106, Valencia, Spain 
 Urology Department, Hospital Germans Trias i Pujol, Carretera de Canyet, S/N, Badalona, Barcelona, Spain 
Pages
1-10
Publication year
2017
Publication date
Aug 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1957270051
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.